Christopher Reid Reilly, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myelodysplastic Syndromes | 4 | 2024 | 1351 | 1.060 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2023 | 80 | 0.840 |
Why?
|
| Lipomatosis | 1 | 2023 | 112 | 0.830 |
Why?
|
| Myeloproliferative Disorders | 3 | 2023 | 603 | 0.830 |
Why?
|
| Bone Marrow Diseases | 1 | 2023 | 230 | 0.770 |
Why?
|
| Telomerase | 1 | 2021 | 729 | 0.560 |
Why?
|
| Genetic Variation | 1 | 2021 | 6540 | 0.270 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2023 | 375 | 0.190 |
Why?
|
| Thrombocythemia, Essential | 1 | 2021 | 103 | 0.190 |
Why?
|
| Polycythemia Vera | 1 | 2021 | 163 | 0.180 |
Why?
|
| Disease Susceptibility | 1 | 2023 | 1780 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2024 | 3770 | 0.130 |
Why?
|
| Telomere | 1 | 2020 | 909 | 0.120 |
Why?
|
| Sulfonamides | 1 | 2024 | 1932 | 0.120 |
Why?
|
| Disease-Free Survival | 2 | 2021 | 6891 | 0.120 |
Why?
|
| Transplantation Conditioning | 1 | 2020 | 1597 | 0.120 |
Why?
|
| Stem Cell Transplantation | 1 | 2020 | 1618 | 0.100 |
Why?
|
| Survival Rate | 2 | 2021 | 12773 | 0.090 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2024 | 3497 | 0.080 |
Why?
|
| Janus Kinase 2 | 2 | 2021 | 527 | 0.080 |
Why?
|
| Prevalence | 1 | 2023 | 15194 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 9185 | 0.060 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2024 | 39 | 0.060 |
Why?
|
| Azacitidine | 1 | 2024 | 347 | 0.050 |
Why?
|
| Clonal Deletion | 1 | 1999 | 79 | 0.040 |
Why?
|
| Melphalan | 1 | 2020 | 431 | 0.040 |
Why?
|
| Self Tolerance | 1 | 1999 | 124 | 0.040 |
Why?
|
| Humans | 8 | 2024 | 742088 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2024 | 1434 | 0.040 |
Why?
|
| Adult | 4 | 2024 | 213712 | 0.030 |
Why?
|
| Autoantigens | 1 | 1999 | 891 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1999 | 1470 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2021 | 2513 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 21596 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 3381 | 0.020 |
Why?
|
| Mutation | 2 | 2021 | 29717 | 0.020 |
Why?
|
| Male | 2 | 2021 | 349538 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1999 | 4379 | 0.020 |
Why?
|
| Female | 2 | 2021 | 379592 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15056 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2021 | 11470 | 0.010 |
Why?
|
| Aged | 2 | 2024 | 162944 | 0.010 |
Why?
|
| Muramidase | 1 | 1999 | 174 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1999 | 517 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 1999 | 251 | 0.010 |
Why?
|
| Middle Aged | 2 | 2021 | 213127 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 1999 | 969 | 0.010 |
Why?
|
| Young Adult | 1 | 2021 | 56350 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1999 | 1264 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 1999 | 1284 | 0.010 |
Why?
|
| Spleen | 1 | 1999 | 2359 | 0.010 |
Why?
|
| Child | 1 | 2021 | 77478 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 85649 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1999 | 6382 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 1999 | 2723 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1999 | 5867 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1999 | 9735 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1999 | 11363 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1999 | 21821 | 0.000 |
Why?
|
| Mice | 1 | 1999 | 81045 | 0.000 |
Why?
|
| Animals | 1 | 1999 | 168561 | 0.000 |
Why?
|